Clinical Trials Browser

Phase 2 × INDUSTRY × ensartinib × Clear all

NCT03215693 2023-08-16

X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04415320 2020-06-04

X-396 (Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases

Phase 2 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03608007 2020-01-09

X-396 Capsule in Advanced NSCLC Patients With ROS1 Gene Rearrangement

Phase 2 Unknown

Lung Neoplasms